The selling is minimal relative to market cap ($23.2B) and appears tied to option exercises and tax obligations, not negative sentiment. Traders should monitor for follow-up filings or commentary around earnings or pipeline updates, but no immediate signal from this cluster.
Price Chart
Executive Summary
Multiple United Therapeutics insiders, including CEO Martine Rothblatt and CFO James Edgemond, engaged in significant stock transactions over the past week, primarily involving derivative exercises and tax-related share withholdings. The open-market sales totaled $684,416, while non-cash transactions (exercises and tax withholdings) amounted to over $10.1 million in value. This cluster reflects routine equity settlement activity rather than strategic selling.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 1,009 shares for $537,803 across three open-market transactions; also exercised derivatives on 61,499 shares at $146.03 strike price
- CFO James Edgemond had $2.51M in tax withholding (F transaction) and exercised derivatives on 10,380 shares (non-cash)
- COO Michael Benkowitz had $4.20M in tax withholding (F transaction)
- EVP Paul Mahon sold 753 shares for $397,184 and exercised derivatives on 17,195 shares
- Director Judy Olian sold 200 shares for $107,088; Director Jan Malcolm sold 45 shares for $24,008
- Total open-market sales: $684,416 across 4 insiders
- Total non-cash transactions (M, F, A): over $10.1 million in value
- All transactions occurred between March 15–19, 2026
Financial Impact
$684,416 in net open-market selling; $10.1M in non-cash derivative settlements and tax withholdings
Risk Factors
- Perception risk from high-dollar tax withholdings, though common in biotech executives with large option grants
- Concentration of transactions around CEO and CFO could draw scrutiny if pattern continues
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (20 trades, 7d window) | cluster-UTHR-1773952260021 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $573.51 (+14.62%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $573.51 (+15.37%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $573.51 (+13.82%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $573.51 (+13.16%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $573.51 (+17.62%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $573.51 (+17.48%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $573.51 (+11.26%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $573.51 (+8.64%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access